Dale J. Boden
Gründer bei Advanced Cancer Therapeutics LLC
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Tyree G. Wilburn | M | 70 |
Advanced Cancer Therapeutics LLC
 Advanced Cancer Therapeutics LLC Pharmaceuticals: MajorHealth Technology Advanced Cancer Therapeutics LLC develops cancer therapeutics. It focuses on the discovery and early development of novel cancer therapeutics as well as selection for partnership, commercialization and manufacture of the most promising discoveries. The company was founded by Dale J. Boden, William Lomicka, and Tyree G. Wilburn in January 2007 and is headquartered in Louisville, KY.
Yearling Management LLC
 Yearling Management LLC Investment ManagersFinance Yearling Management LLC (Yearling Management) is a venture capital firm founded in 2001 by Ty Wilburn. The firm is headquartered in Louisville, Kentucky. | 22 Jahre |
| Kenneth S. Berryman | M | - |
Weller Equity Management LLC
 Weller Equity Management LLC Investment ManagersFinance Weller Equity Management LLC (Weller Equity Partners) is a private equity firm founded in 2015 by Kenneth S. Berryman and Dale J. Boden. The firm is headquartered in Louisville, Kentucky.
Mirac Investment LLC
 Mirac Investment LLC Financial ConglomeratesFinance Mirac Investment LLC operates as an investment holding company. The company is headquartered in Louisville, KY. | 9 Jahre |
| Ross Jordan | M | - |
Yearling Management LLC
Yearling Management LLC Investment ManagersFinance Yearling Management LLC (Yearling Management) is a venture capital firm founded in 2001 by Ty Wilburn. The firm is headquartered in Louisville, Kentucky.
Weller Equity Management LLC
Weller Equity Management LLC Investment ManagersFinance Weller Equity Management LLC (Weller Equity Partners) is a private equity firm founded in 2015 by Kenneth S. Berryman and Dale J. Boden. The firm is headquartered in Louisville, Kentucky.
Mirac Investment LLC
Mirac Investment LLC Financial ConglomeratesFinance Mirac Investment LLC operates as an investment holding company. The company is headquartered in Louisville, KY. | 11 Jahre |
| Serge R. Martinod | M | - |
TNG Pharmaceuticals, Inc.
 TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | 12 Jahre |
| Donald Miller | M | - |
Advanced Cancer Therapeutics LLC
Advanced Cancer Therapeutics LLC Pharmaceuticals: MajorHealth Technology Advanced Cancer Therapeutics LLC develops cancer therapeutics. It focuses on the discovery and early development of novel cancer therapeutics as well as selection for partnership, commercialization and manufacture of the most promising discoveries. The company was founded by Dale J. Boden, William Lomicka, and Tyree G. Wilburn in January 2007 and is headquartered in Louisville, KY.
University of Louisville
| - |
| Larry Horn | M | - |
TNG Pharmaceuticals, Inc.
TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | 15 Jahre |
| Brian Lavin | M | - |
University of Louisville
| - |
| Randall B. Riggs | M | 57 |
Advanced Cancer Therapeutics LLC
Advanced Cancer Therapeutics LLC Pharmaceuticals: MajorHealth Technology Advanced Cancer Therapeutics LLC develops cancer therapeutics. It focuses on the discovery and early development of novel cancer therapeutics as well as selection for partnership, commercialization and manufacture of the most promising discoveries. The company was founded by Dale J. Boden, William Lomicka, and Tyree G. Wilburn in January 2007 and is headquartered in Louisville, KY. | 17 Jahre |
| J. Nichols | M | 81 |
Louisville Regional Airport Authority (Kentucky)
| 32 Jahre |
| Mark Slaughter | M | - |
University of Louisville
| - |
| Terry L. Singer | M | - |
University of Louisville
| - |
| Adel S. Elmaghraby | M | - |
University of Louisville
| - |
| Robert Lewis Taylor | M | 84 |
University of Louisville
| - |
| Philip J. Lynch | M | - |
Louisville Regional Airport Authority (Kentucky)
| 14 Jahre |
| Ron Butt | M | - |
University of Louisville
| - |
| James C. Seiffert | M | - |
University of Louisville
| 21 Jahre |
| Rounsavall W. Robert | M | - |
Advanced Cancer Therapeutics LLC
Advanced Cancer Therapeutics LLC Pharmaceuticals: MajorHealth Technology Advanced Cancer Therapeutics LLC develops cancer therapeutics. It focuses on the discovery and early development of novel cancer therapeutics as well as selection for partnership, commercialization and manufacture of the most promising discoveries. The company was founded by Dale J. Boden, William Lomicka, and Tyree G. Wilburn in January 2007 and is headquartered in Louisville, KY. | - |
| Jean Bandos | F | - |
University of Louisville
| - |
| Michael J. Curtin | M | - |
University of Louisville
| 39 Jahre |
| Roland Valdes | M | - |
University of Louisville
| - |
| Mahendra Kumar Sunkara | M | 59 |
University of Louisville
| - |
| Gustavo A. Perez-Abadia | M | - |
University of Louisville
| - |
| Norman D. Radtke | M | - |
University of Louisville
| - |
| Albert R. Cunningham | M | - |
University of Louisville
| - |
| Herbert W. Perkins | M | - |
University of Louisville
| - |
| Robert D. Dowling | M | - |
University of Louisville
| - |
| Roderick D. Purdy | M | - |
University of Louisville
| - |
| Jason Tomlinson | M | - |
University of Louisville
| - |
| Butch L. Mercer | M | - |
TNG Pharmaceuticals, Inc.
TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | - |
| R. Ted Steinbock | M | - |
Advanced Cancer Therapeutics LLC
Advanced Cancer Therapeutics LLC Pharmaceuticals: MajorHealth Technology Advanced Cancer Therapeutics LLC develops cancer therapeutics. It focuses on the discovery and early development of novel cancer therapeutics as well as selection for partnership, commercialization and manufacture of the most promising discoveries. The company was founded by Dale J. Boden, William Lomicka, and Tyree G. Wilburn in January 2007 and is headquartered in Louisville, KY. | - |
| Stuart K. Williams | M | - |
University of Louisville
| - |
| John Karman | M | - |
University of Louisville
| - |
| Ellsworth Collins | M | - |
University of Louisville
| - |
| John F. Naber | M | - |
University of Louisville
| - |
| David Potash | M | - |
University of Louisville
| - |
| James P. Dailey | M | - |
University of Louisville
| - |
| J. McCauley Brown | M | 71 |
University of Louisville
| - |
| Kelly M. McMasters | M | 63 |
University of Louisville
| 28 Jahre |
| Roger W. Schipke | M | 87 |
University of Louisville
| 22 Jahre |
| Stanley A. Gall | M | - |
University of Louisville
| - |
| Sandra Metts Snowden | F | 78 |
University of Louisville
| - |
| Phoebe Wood | F | 70 |
TNG Pharmaceuticals, Inc.
TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | - |
| Robert D. Nixon | M | 73 |
University of Louisville
| - |
| Wendy C. Welsh | F | 70 |
University of Louisville
| - |
| George R. Siemens | M | 74 |
University of Louisville
| - |
| Skip Miller | M | - |
Louisville Regional Airport Authority (Kentucky)
| - |
| Ricky May | M | - |
University of Louisville
| 40 Jahre |
| James Sublett | M | - |
University of Louisville
| - |
| Kent R. van Kampen | M | - |
TNG Pharmaceuticals, Inc.
TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | - |
| Fred J. Roisen | M | - |
University of Louisville
| 38 Jahre |
| Haval Shirwan | M | - |
University of Louisville
| - |
| Dana Bowers | F | - |
University of Louisville
| - |
| Steven T. Hester | M | - |
University of Louisville
| - |
| Stephen J. Pollard | M | - |
University of Louisville
| - |
| Evelyn Strange | F | - |
Louisville Regional Airport Authority (Kentucky)
| 12 Jahre |
| Christopher Brennan | M | 68 |
University of Louisville
| - |
| Sharon Moore | M | - |
University of Louisville
| - |
| Larry N. Cook | M | - |
University of Louisville
| - |
| William P. Hnat | M | - |
University of Louisville
| - |
| Bill H. Lomicka | M | 86 |
Yearling Management LLC
Yearling Management LLC Investment ManagersFinance Yearling Management LLC (Yearling Management) is a venture capital firm founded in 2001 by Ty Wilburn. The firm is headquartered in Louisville, Kentucky. | - |
| Angela Curry | F | 51 |
University of Louisville
| - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Bretherton | M | 68 |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Michael G. Pappas | M | 68 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 16 Jahre |
| Glyn Owain Edwards | M | 68 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 13 Jahre |
| Jonathan Morley-Kirk | M | 60 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Kevin Kissane | M | 69 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Michael Lewis | M | 66 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 3 Jahre |
| Ursula Ney | M | 72 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 6 Jahre |
| Daniel W. Elger | M | 54 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 6 Jahre |
| Grahame Cook | M | 66 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 12 Jahre |
| Barry James Price | M | 80 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 14 Jahre |
| Michael A. Boss | M | 69 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Ann V. Hacker | F | - |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Gary Acton | M | 65 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Birgit Stattin Norinder | F | 75 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | 8 Jahre |
| Ross Andrew Hollyman | M | 54 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| Eric Todd | M | - |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | - |
| William Lomicka | M | - |
Advanced Cancer Therapeutics LLC
Advanced Cancer Therapeutics LLC Pharmaceuticals: MajorHealth Technology Advanced Cancer Therapeutics LLC develops cancer therapeutics. It focuses on the discovery and early development of novel cancer therapeutics as well as selection for partnership, commercialization and manufacture of the most promising discoveries. The company was founded by Dale J. Boden, William Lomicka, and Tyree G. Wilburn in January 2007 and is headquartered in Louisville, KY. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 62 | 79,49% |
| Vereinigtes Königreich | 16 | 20,51% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Dale J. Boden
- Persönliches Netzwerk
